PPARGC1A and nervous system disorder: Whether PGC-1α supplementation and which compounds could open promising avenues for neuroprotective therapeutics among neurological diseases, or even within a specific neurological disease, merits further rigorous preclinical studies and decisive evaluation through clinical trials.